The Buffalo Neuroimaging Analysis Center (BNAC) is a dedicated research center that has expertise in developing innovative MRI techniques and methods through a multi-disciplinary team of MR physicists, computer scientists, and clinical neuroimagers. By leveraging new advances in machine learning and artificial intelligence (AI), BNAC has been able to develop numerous new MRI acquisition and analysis methods that are capable of analyzing large-scale datasets with tens of thousands of scans across multiple timepoints in thousands of individuals.
Deep learning is a state-of-the-art technique for developing computer vision methods capable of rivaling or even exceeding human-level ability in specific areas. In addition to the development of new MRI techniques, BNAC has also been working to integrate deep learning systems into research workflows to improve overall study quality and precision. Unlike most research datasets, which are often curated by single investigators (or even trainees), BNAC uses a three-level quality control system where scans are reviewed by multiple evaluators and resulting gold-standard ROIs are painstakingly edited to ensure the highest possible accuracy. This in turn provides unparalleled training data for us to teach AI systems to identify and delineate brain regions and areas of pathology. By feeding this back into clinical trial activities, we can augment human operators to further improve precision of lesion delineation and accuracy of lesion detection.
Another highlight of BNAC’s AI activities includes the development of a translational tool to measure thalamic volume on real-world clinical images. The thalamus is involved in many neurological functions and is a critical structure for examining neurodegeneration in MS and other diseases. BNAC developed a deep-learning method called DeepGRAI (Deep Gray Rating via Artificial Intelligence) for measurement of this important biomarker on conventional T2-FLAIR MR images, while providing accuracy rivaling the best research-quality sequences.
Results of DeepGRAI segmentation algorithm on cases with very high (left) and low (right) levels of atrophy. The classifier performs on clinical routine T2-FLAIR images well in both cases despite substantial differences in brain morphology and lesion volume.
For more information about clinical and preclinical imaging endpoints, click here.
FEATURED RECENT INNOVATIVE MRI TECHNIQUES/AI STUDIES
Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman D, Benedict RH, Riolo J, Silva D,
Dwyer MG, on behalf of the DeepGRAI Registry Study group. Thalamic atrophy measured by
artificial intelligence in a multi-center clinical routine real-word study is associated with disability
progression. JNNP 2022;doi:10.1136/jnnp-2022-329333. [Open Article]
Jakimovski D, Zivadinov R, Bergsland N, Oh J, Martin M, Shinohara RT, Bakshi R, Calabresi PA,
Papinutto N, Pelletier D, Dwyer MG on behalf of North American Imaging in Multiple Sclerosis
(NAIMS) (2022). Multi-site reproducibility of lateral ventricular volume using the NAIMS
cooperative pilot dataset. J Neuroimaging;doi: 32(5):910-919. [Open Article]
Contact Our Group Today
Part of BNAC’s mission is to help share our tools and experience with our colleagues and other industry partners. If you need help with advanced MRI analysis techniques and AI in your research or clinical trial work, please reach out to discuss how we can assist. Our group brings decades of experience and expertise to every collaborative study and service partnership.